Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_23094 | 371 | 7.74 | Mlig455_021969 | Neo: - Age: - Region-enriched R3: 4.168/0.00000 |
Mlig455_021969 {REF} {Length: 4499} {TRANSSPLICED} {RNA1509_12504, RNA1509_30322} {RNA1310_3897, RNA1509_30322} {RNA1509_30322, RNA815_21452} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | -5.622 | 3.359 | 1.00000 | 1.00000 | |
RegionR2 | -0.938 | 3.359 | 0.93746 | 1.00000 | |
RegionR3 | 4.168 | 3.359 | 0.00000 | 0.00000 | |
RegionR4 | 1.888 | 3.359 | 0.03999 | 0.16554 | |
RegionR5 | 1.722 | 3.359 | 0.06713 | 0.23109 | |
RegionR6 | 1.589 | 3.359 | 0.13457 | 0.65878 | |
RegionR7 | 1.226 | 3.359 | 0.37064 | 1.00000 | |
RegionR8 | -4.033 | 3.359 | 0.99987 | 1.00000 |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | 8.613 | 3.359 | 0.00797 | 0.41294 | |
RegenerationR2 | 2.277 | 3.359 | 0.00963 | 0.15726 | |
RegenerationR3 | 0.336 | 3.359 | 0.48538 | 0.85312 | |
RegenerationR4 | 1.129 | 3.359 | 0.03141 | 0.28604 | |
RegenerationR5 | 1.075 | 3.359 | 0.03451 | 0.30897 | |
RegenerationR6 | 0.769 | 3.359 | 0.21365 | 0.55730 | |
RegenerationBL | -0.19 | 3.359 | 0.82783 | 1.00000 | |
RegenerationTP | 3.34 | 3.359 | 0.05056 | 0.36875 |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_23094 | 371 | 7.74 | Mlig455_021969 | Neo: - Age: - Region-enriched R3: 4.168/0.00000 |
6 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | Mlig455_021969 {REF} {Length: 4499} {TRANSSPLICED} {RNA1509_12504, RNA1509_30322} {RNA1310_3897, RNA1509_30322} {RNA1509_30322, RNA815_21452} | |
2. | MligTC455_23093 | 345 | 7.19 | Mlig455_021893 | Neo: - Age: Down-Up-Up Region-enriched R3: 3.624/0.00000 |
4.58 | 0.835 | 0.943 | 0.940 | 0.961 | 0.901 | - | Mlig455_021893 {REF} {Length: 1735} {RNA1509_30322, RNA1509_50391} {RNA1310_32503, RNA1509_50391} {RNA1509_50391, RNA815_39630} | |
3. | MligTC455_33254 | 462 | 9.62 | Mlig455_055163 | Neo: - Age: logFC(26M/2M)=0.785 Region-enriched R3: 4.000/0.00000 |
VCAN | 3.445 | 0.866 | 0.824 | - | 0.950 | 0.805 | - | Mlig455_055163 {REF} {Length: 2071} {Pfam: Lectin C-type domain [PF00059.23, score=67.8]; UL45 protein, carbohydrate-binding C-type lectin-like [PF05473.14, score=27.6]} {Human: ENSG00000038427, VCAN, versican, [Score=54.3, Expect=7e-07]; ENSG00000152672, CLEC4F, C-type lectin domain family 4 member F, [Score=53.1, Expect=1e-06]} {Mouse: ENSMUSG00000021614, Vcan, versican, [Score=55.1, Expect=3e-07]} {Celegans: WBGene00020191, clec-53, C-type LECtin, [Score=62.4, Expect=2e-10]} {Smed: dd_Smed_v6_1489_0_1, dd_Smed_v6_1489_0_1, [Score=51.2, Expect=1e-06]} {RNA1509_25541} {RNA1310_14728} {RNA815_4830.2} |
4. | MligTC455_33253 | 470 | 9.79 | Mlig455_006829 | Neo: - Age: Up-Down-Up, logFC(26M/2M)=0.763 Region-enriched R3: 3.956/0.00000 |
3.44 | 0.872 | 0.814 | - | 0.952 | 0.802 | - | Mlig455_006829 {REF} {Length: 2010} {Pfam: Lectin C-type domain [PF00059.23, score=70.0]; UL45 protein, carbohydrate-binding C-type lectin-like [PF05473.14, score=22.2]} {Celegans: WBGene00020191, clec-53, C-type LECtin, [Score=61.2, Expect=6e-10]} {Smed: dd_Smed_v6_1489_0_1, dd_Smed_v6_1489_0_1, [Score=47.8, Expect=1e-05]} {RNA1509_25541} {RNA1310_14728} {RNA815_4830.2} | |
5. | MligTC455_47182 | 14582 | 303.8 | Mlig455_058015, Mlig455_058180, Mlig455_058206 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.558 Region-enriched R3: 3.886/0.00000 |
GM2A | 3.354 | 0.914 | 0.712 | - | 0.956 | 0.772 | - | Mlig455_058015 {REF} {Length: 1913} {Pfam: ML domain [PF02221.17, score=41.0]} {Human: ENSG00000196743, GM2A, GM2 ganglioside activator, [Score=52.0, Expect=4e-08]} {Mouse: ENSMUSG00000000594, Gm2a, GM2 ganglioside activator protein, [Score=53.9, Expect=6e-09]} {Smed: dd_Smed_v6_214_1_1, dd_Smed_v6_214_1_1, [Score=73.9, Expect=6e-17]} {RNA1509_4247} {RNA1310_43150} {RNA815_23642.1} Mlig455_058180 {REF} {Length: 1416} {Pfam: ML domain [PF02221.17, score=41.0]} {Human: ENSG00000196743, GM2A, GM2 ganglioside activator, [Score=52.0, Expect=4e-08]} {Mouse: ENSMUSG00000000594, Gm2a, GM2 ganglioside activator protein, [Score=53.9, Expect=6e-09]} {Smed: dd_Smed_v6_214_1_1, dd_Smed_v6_214_1_1, [Score=73.9, Expect=6e-17]} {RNA1509_4247} {RNA1310_43150} {RNA815_23642.1} Mlig455_058206 {REF} {Length: 1589} {Pfam: ML domain [PF02221.17, score=41.0]} {Human: ENSG00000196743, GM2A, GM2 ganglioside activator, [Score=52.0, Expect=4e-08]} {Mouse: ENSMUSG00000000594, Gm2a, GM2 ganglioside activator protein, [Score=53.9, Expect=6e-09]} {Smed: dd_Smed_v6_214_1_1, dd_Smed_v6_214_1_1, [Score=73.9, Expect=6e-17]} {RNA1509_3837, RNA1509_4247, RNA1509_4841, RNA1509_5347} {RNA1310_43150, RNA1509_3837, RNA1509_4247, RNA1509_4841, RNA1509_5347} {RNA1509_3837, RNA1509_4247, RNA1509_4841, RNA1509_5347, RNA815_23642.1} |
6. | MligTC455_27242 | 14489 | 301.86 | Mlig455_056957 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.849 Region-enriched R3: 2.848/0.00000 |
GM2A | 3.294 | 0.818 | 0.765 | - | 0.761 | 0.950 | - | Mlig455_056957 {REF} {Length: 877} {Pfam: ML domain [PF02221.17, score=41.0]} {Human: ENSG00000196743, GM2A, GM2 ganglioside activator, [Score=51.6, Expect=7e-08]} {Mouse: ENSMUSG00000000594, Gm2a, GM2 ganglioside activator protein, [Score=50.8, Expect=1e-07]} {Smed: dd_Smed_v6_214_1_1, dd_Smed_v6_214_1_1, [Score=56.2, Expect=3e-10]} {RNA1509_960} {RNA1310_28835.1} {RNA815_6681.1} |
7. | MligTC455_43194 | 11396 | 237.42 | Mlig455_009763, Mlig455_070122 | Neo: - Age: Down-Down-Up Region-enriched R3: 2.399/0.00716 |
CST3 | 2.678 | 0.862 | - | - | 0.952 | 0.864 | - | Mlig455_009763 {REF} {Length: 720} {Pfam: Cystatin domain [PF00031.23, score=28.8]} {Human: ENSG00000101439, CST3, cystatin C, [RH, Score=44.7, Expect=6e-06]} {RNA1509_26463, RNA1509_2883, RNA1509_6502} {RNA1310_51190, RNA1509_2883, RNA1509_6502} {RNA1509_2883, RNA1509_6502, RNA815_25269} Mlig455_070122 {REF} {Length: 736} {Pfam: Cystatin domain [PF00031.23, score=28.8]} {Human: ENSG00000101439, CST3, cystatin C, [RH, Score=44.7, Expect=6e-06]} {RNA1509_26463, RNA1509_4516, RNA1509_5046, RNA1509_7022} {RNA1310_51190, RNA1509_26463, RNA1509_4516, RNA1509_5046, RNA1509_7022} {RNA1509_26463, RNA1509_4516, RNA1509_5046, RNA1509_7022, RNA815_25269} |
8. | MligTC455_18468 | 49 | 1.02 | Mlig455_014453 | Neo: - Age: - Region-enriched R4: 3.552/0.03158 |
2.661 | 0.744 | - | - | 0.956 | 0.961 | - | Mlig455_014453 {REF} {Length: 1446} {Pfam: Lipase (class 3) [PF01764.27, score=96.6]} {Celegans: WBGene00022457, Y110A7A.7, [Score=158, Expect=6e-45]} {RNA1509_36256} {RNA1310_22408} {RNA815_9975} | |
9. | MligTC455_46997 | 1302 | 27.12 | Mlig455_018324 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=2.900 Region-enriched R4: 3.072/0.00026 |
CPA2 | 2.631 | 0.786 | - | - | 0.892 | 0.953 | - | Mlig455_018324 {REF} {Length: 1747} {Pfam: Zinc carboxypeptidase [PF00246.26, score=269.1]; Carboxypeptidase activation peptide [PF02244.18, score=54.2]} {Human: ENSG00000158516, CPA2, carboxypeptidase A2, [RH, Score=287, Expect=3e-93]} {Mouse: ENSMUSG00000071553, Cpa2, carboxypeptidase A2, pancreatic, [RH, Score=288, Expect=2e-93]} {Dmel: FBgn0029807, CG3108, [RH, Score=266, Expect=8e-80]} {Celegans: WBGene00008521, F02D8.4, [RH, Score=251, Expect=3e-79]} {Smed: dd_Smed_v6_5999_0_1, dd_Smed_v6_5999_0_1, [RH, Score=254, Expect=1e-80]} {RNA1509_11873, RNA1509_20365} {RNA1310_21434, RNA1509_11873, RNA1509_20365} {RNA1509_11873, RNA1509_20365, RNA815_8679} |
10. | MligTC455_11766 | 201 | 4.18 | Mlig455_048732 | Neo: - Age: - Region-enriched R3: 3.689/0.00006 |
2.525 | 0.779 | - | - | 0.787 | 0.959 | - | Mlig455_048732 {REF} {Length: 376} {NoTransDecoderORF} {RNA1310_75754} {RNA815_50709.2} | |
11. | MligTC455_36083 | 1788 | 37.26 | Mlig455_050276 | Neo: - Age: Down-Down-Up Region-enriched R3: 2.753/0.00000 |
2.505 | 0.819 | 0.729 | - | 0.957 | - | - | Mlig455_050276 {REF} {Length: 2874} {Pfam: Transforming growth factor beta like domain [PF00019.22, score=19.6]} {RNA1509_5434} {RNA1310_5336} {RNA815_1739.1} | |
12. | MligTC455_52856 | 135 | 2.82 | Mlig455_040428 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=2.836 Region-enriched R3: 4.616/0.00003 |
MCFD2 | 1.853 | 0.896 | - | - | 0.957 | - | - | Mlig455_040428 {REF} {Length: 998} {Pfam: EF-hand domain pair [PF13499.8, score=45.6]; EF-hand domain [PF13405.8, score=36.2]; EF hand [PF00036.34, score=36.1]; EF-hand domain pair [PF13833.8, score=25.7]} {Human: ENSG00000180398, MCFD2, multiple coagulation factor deficiency 2, [Score=62.0, Expect=5e-12]} {Mouse: ENSMUSG00000024150, Mcfd2, multiple coagulation factor deficiency 2, [Score=60.1, Expect=2e-11]} {Dmel: FBgn0037798, CG12817, [RH, Score=53.5, Expect=6e-09]} {Celegans: WBGene00010075, F55A11.1, [RH, Score=70.1, Expect=3e-15]} {RNA1509_28625} {RNA1310_37099} {RNA815_18915} |
13. | MligTC455_38555 | 1592 | 33.16 | Mlig455_042871, Mlig455_042872, Mlig455_042880 | Neo: - Age: Down-Up-Down Region-enriched R3: 3.619/0.00000 |
AMY1B, AMY1C, AMY2B | 1.841 | 0.873 | - | - | 0.968 | - | - | Mlig455_042871 {REF} {Length: 656} {Human: ENSG00000240038, AMY2B, amylase, alpha 2B (pancreatic), [Score=136, Expect=1e-38]; ENSG00000243480, AMY2A, amylase, alpha 2A (pancreatic), [Score=135, Expect=5e-40]; ENSG00000174876, AMY1B, amylase, alpha 1B (salivary), [Score=133, Expect=6e-39]; ENSG00000237763, AMY1A, amylase, alpha 1A (salivary), [Score=133, Expect=6e-39]; ENSG00000187733, AMY1C, amylase, alpha 1C (salivary), [Score=132, Expect=2e-36]} {Mouse: ENSMUSG00000074264, Amy1, amylase 1, salivary, [Score=131, Expect=6e-38]; ENSMUSG00000070360, Amy2a1, amylase 2a1, [Score=125, Expect=8e-36]} {Dmel: FBgn0020506, Amyrel, [Score=122, Expect=6e-33]} {Celegans: WBGene00008220, C50B6.7, Alpha-amylase, [Score=106, Expect=4e-27]} {RNA1509_1421} {RNA1310_11165} {RNA815_3708.1} Mlig455_042872 {REF} {Length: 1146} {Pfam: Alpha amylase, C-terminal all-beta domain [PF02806.20, score=43.6]} {Human: ENSG00000174876, AMY1B, amylase, alpha 1B (salivary), [Score=315, Expect=1e-104]; ENSG00000237763, AMY1A, amylase, alpha 1A (salivary), [Score=315, Expect=1e-104]; ENSG00000187733, AMY1C, amylase, alpha 1C (salivary), [Score=315, Expect=1e-104]; ENSG00000240038, AMY2B, amylase, alpha 2B (pancreatic), [Score=312, Expect=3e-103]; ENSG00000243480, AMY2A, amylase, alpha 2A (pancreatic), [Score=312, Expect=2e-103]} {Mouse: ENSMUSG00000096569, Amy2a2, amylase 2a2, [Score=317, Expect=3e-105]; ENSMUSG00000096770, Amy2a4, amylase 2a4, [Score=317, Expect=3e-105]; ENSMUSG00000093931, Amy2a3, amylase 2a3, [Score=317, Expect=3e-105]; ENSMUSG00000074268, Amy2a5, amylase 2a5, [Score=317, Expect=3e-105]; ENSMUSG00000074264, Amy1, amylase 1, salivary, [Score=310, Expect=1e-102]} {Dmel: FBgn0000078, Amy-d, Amylase distal, [Score=269, Expect=7e-87]} {Celegans: WBGene00008220, C50B6.7, Alpha-amylase, [Score=154, Expect=4e-42]} {RNA1509_1421} {RNA1310_7529} {RNA815_3708.1} Mlig455_042880 {REF} {Length: 1770} {Pfam: Alpha amylase, catalytic domain [PF00128.26, score=56.3]; Alpha amylase, C-terminal all-beta domain [PF02806.20, score=42.2]} {Human: ENSG00000187733, AMY1C, amylase, alpha 1C (salivary), [RH, Score=588, Expect=0.0]; ENSG00000174876, AMY1B, amylase, alpha 1B (salivary), [RH, Score=588, Expect=0.0]; ENSG00000237763, AMY1A, amylase, alpha 1A (salivary), [RH, Score=588, Expect=0.0]; ENSG00000240038, AMY2B, amylase, alpha 2B (pancreatic), [RH, Score=587, Expect=0.0]; ENSG00000243480, AMY2A, amylase, alpha 2A (pancreatic), [RH, Score=585, Expect=0.0]} {Mouse: ENSMUSG00000074264, Amy1, amylase 1, salivary, [RH, Score=580, Expect=0.0]; ENSMUSG00000096770, Amy2a4, amylase 2a4, [RH, Score=570, Expect=0.0]; ENSMUSG00000074268, Amy2a5, amylase 2a5, [RH, Score=570, Expect=0.0]; ENSMUSG00000093931, Amy2a3, amylase 2a3, [RH, Score=570, Expect=0.0]; ENSMUSG00000096569, Amy2a2, amylase 2a2, [RH, Score=570, Expect=0.0]} {Dmel: FBgn0000078, Amy-d, Amylase distal, [RH, Score=492, Expect=4e-171]} {Celegans: WBGene00008220, C50B6.7, Alpha-amylase, [Score=358, Expect=6e-116]} {RNA1509_1421} {RNA1310_7529} {RNA815_3708.1} |
14. | MligTC455_16020 | 273 | 5.69 | Mlig455_052333 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.890 Region-enriched R3: 4.114/0.00000 |
1.84 | - | - | - | 0.889 | 0.951 | - | Mlig455_052333 {REF} {Length: 1687} {Pfam: RING-type zinc-finger [PF13445.8, score=22.8]; Zinc finger, C3HC4 type (RING finger) [PF13920.8, score=20.2]} {RNA1509_36870} {RNA1310_20406} {RNA815_6394} | |
15. | MligTC455_42922 | 1184 | 24.67 | Mlig455_026345 | Neo: - Age: logFC(26M/2M)=0.973 Region-enriched R3: 3.300/0.00000 |
1.839 | 0.861 | - | - | 0.978 | - | - | Mlig455_026345 {REF} {Length: 2368} {Pfam: Group 7 allergen [PF16984.7, score=52.6]} {RNA1509_14255} {RNA1310_17894, RNA1509_14255} {RNA1509_14255, RNA815_9024} | |
16. | MligTC455_38556 | 168 | 3.5 | Mlig455_049546 | Neo: - Age: logFC(26M/2M)=-0.547 Region-enriched R3: 4.481/0.00055 |
AMY1C | 1.789 | 0.834 | - | - | 0.955 | - | - | Mlig455_049546 {REF} {Length: 2273} {Pfam: Alpha amylase, catalytic domain [PF00128.26, score=54.2]; Alpha amylase, C-terminal all-beta domain [PF02806.20, score=41.8]} {Human: ENSG00000187733, AMY1C, amylase, alpha 1C (salivary), [RH, Score=592, Expect=0.0]; ENSG00000237763, AMY1A, amylase, alpha 1A (salivary), [RH, Score=592, Expect=0.0]; ENSG00000174876, AMY1B, amylase, alpha 1B (salivary), [RH, Score=592, Expect=0.0]; ENSG00000240038, AMY2B, amylase, alpha 2B (pancreatic), [RH, Score=591, Expect=0.0]; ENSG00000243480, AMY2A, amylase, alpha 2A (pancreatic), [RH, Score=588, Expect=0.0]} {Mouse: ENSMUSG00000074264, Amy1, amylase 1, salivary, [RH, Score=584, Expect=0.0]; ENSMUSG00000096770, Amy2a4, amylase 2a4, [RH, Score=575, Expect=0.0]; ENSMUSG00000096569, Amy2a2, amylase 2a2, [RH, Score=575, Expect=0.0]; ENSMUSG00000093931, Amy2a3, amylase 2a3, [RH, Score=575, Expect=0.0]; ENSMUSG00000074268, Amy2a5, amylase 2a5, [RH, Score=575, Expect=0.0]} {Dmel: FBgn0000078, Amy-d, Amylase distal, [RH, Score=492, Expect=5e-171]} {Celegans: WBGene00008220, C50B6.7, Alpha-amylase, [Score=359, Expect=2e-116]} {RNA1509_1421} {RNA1310_11165, RNA1509_1421} {RNA1509_1421, RNA815_3708.1} |
17. | MligTC455_18466 | 2786 | 58.04 | Mlig455_005607 | Neo: - Age: logFC(26M/2M)=0.391 Region-enriched R3: 1.999/0.00016 |
1.72 | 0.755 | - | - | - | 0.965 | - | Mlig455_005607 {REF} {Length: 1941} {Pfam: Lipase (class 3) [PF01764.27, score=94.6]} {Celegans: WBGene00022457, Y110A7A.7, [Score=154, Expect=9e-44]} {RNA1509_36256, RNA1509_4777, RNA1509_8532} {RNA1310_22408, RNA1509_36256, RNA1509_4777, RNA1509_8532} {RNA1509_36256, RNA1509_4777, RNA1509_8532, RNA815_9975} | |
18. | MligTC455_24537 | 46 | 0.96 | Mlig455_009280 | Neo: - Age: logFC(26M/2M)=1.720 Region-enriched R4: 3.726/0.04899 |
P4HB | 1.687 | 0.725 | - | - | 0.962 | - | - | Mlig455_009280 {REF} {Length: 2535} {Pfam: Thioredoxin [PF00085.22, score=151.6]; Thioredoxin-like domain [PF13848.8, score=137.0]; Thioredoxin-like [PF13905.8, score=36.7]; Calsequestrin [PF01216.19, score=30.9]; ERp29, N-terminal domain [PF07912.15, score=29.5]; Thioredoxin-like [PF13899.8, score=27.9]; Thioredoxin-like domain [PF13098.8, score=27.8]; OST3 / OST6 family, transporter family [PF04756.15, score=26.5]; AhpC/TSA family [PF00578.23, score=19.0]} {Human: ENSG00000185624, P4HB, prolyl 4-hydroxylase subunit beta, [Score=416, Expect=4e-140]} {Mouse: ENSMUSG00000025130, P4hb, prolyl 4-hydroxylase, beta polypeptide, [Score=416, Expect=5e-140]} {Dmel: FBgn0014002, Pdi, Protein disulfide isomerase, [Score=381, Expect=4e-127]} {Celegans: WBGene00003963, pdi-2, Protein disulfide-isomerase 2, [Score=402, Expect=3e-135]} {Smed: dd_Smed_v6_250_0_1, dd_Smed_v6_250_0_1, [Score=419, Expect=4e-142]} {RNA1509_26478} {RNA1310_9678, RNA1509_26478} {RNA1509_26478, RNA815_5042} |
19. | MligTC455_12593 | 435 | 9.05 | Mlig455_001017, Mlig455_064255 | Neo: Irradiation Age: - Region-specific R5: 4.552 Region-enriched R5: 3.735/0.00000 |
OVCH1, TMPRSS7 | 0.962 | - | - | - | 0.962 | - | - | Mlig455_001017 {REF} {Length: 2588} {Pfam: CUB domain [PF00431.22, score=66.2]; Low-density lipoprotein receptor domain class A [PF00057.20, score=62.9]; Trypsin [PF00089.28, score=26.2]} {Human: ENSG00000176040, TMPRSS7, transmembrane serine protease 7, [Score=86.7, Expect=3e-18]; ENSG00000187045, TMPRSS6, transmembrane serine protease 6, [Score=82.4, Expect=7e-17]} {Mouse: ENSMUSG00000033177, Tmprss7, transmembrane serine protease 7, [Score=88.6, Expect=5e-19]; ENSMUSG00000031995, St14, suppression of tumorigenicity 14 (colon carcinoma), [Score=84.3, Expect=1e-17]} {Dmel: FBgn0066101, LpR1, Lipophorin receptor 1, [Score=73.2, Expect=5e-14]} {Celegans: WBGene00020481, T13C2.6, [Score=73.9, Expect=2e-14]} {Smed: dd_Smed_v6_9829_0_1, dd_Smed_v6_9829_0_1, [Score=58.9, Expect=1e-09]} {RNA1509_47790} {RNA1310_12212.1} {RNA815_13365} Mlig455_064255 {REF} {Length: 2400} {Pfam: Trypsin [PF00089.28, score=246.4]; Low-density lipoprotein receptor domain class A [PF00057.20, score=65.2]; CUB domain [PF00431.22, score=65.1]; Trypsin-like peptidase domain [PF13365.8, score=29.0]; Domain of unknown function (DUF1986) [PF09342.13, score=24.6]} {Human: ENSG00000187950, OVCH1, ovochymase 1, [RH, Score=209, Expect=5e-58]} {Mouse: ENSMUSG00000016942, Tmprss6, transmembrane serine protease 6, [RH, Score=224, Expect=2e-64]} {Dmel: FBgn0042098, CG18735, [RH, Score=185, Expect=1e-53]} {Celegans: WBGene00006619, try-1, TRYpsin-like protease, [RH, Score=165, Expect=6e-47]} {Smed: dd_Smed_v6_790_0_1, dd_Smed_v6_790_0_1, [Score=179, Expect=3e-48]} {RNA1509_27528, RNA1509_57567} {RNA1310_12212.1, RNA1509_27528, RNA1509_57567} {RNA1509_27528, RNA1509_57567, RNA815_13365} |